Research programme : psychiatric disorders therapurtics - Lophora
Latest Information Update: 22 May 2024
At a glance
- Originator Lophora
- Class Behavioural disorder therapies; Small molecules
- Mechanism of Action Serotonin 2A receptor partial agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Psychiatric disorders
Most Recent Events
- 30 Apr 2024 Early research in Psychiatric disorders in USA (unspecified route), prior to April 2024 (Lophora pipeline, April 2024)
- 06 Nov 2020 Lophora has patent protection for psychiatric disorders therapurtics worldwide (Lophora website, April 2024)
- 06 Nov 2020 Lophora has patent pending for psychiatric disorders therapurtics worldwide (Lophora webiste, April 2024)